DIETARY arginine availability directly drives MHC class I translation to enhance host immunity against cancer and viral infection. Investigators have demonstrated that specific amino acid availability functions as a metabolic switch governing major histocompatibility complex class I antigen presentation, establishing a direct link between systemic nutrition and immune surveillance.
Role of Dietary Arginine in MHC Class I Translation
Major histocompatibility complex class I molecules present endogenously synthesized peptide fragments to cytotoxic CD8+ T cells. Genes encoding these antigen presenting complexes feature a high frequency of specific codons for arginine. When cellular concentrations of dietary arginine decline, ribosome stalling occurs preferentially at these arginine codons, selectively inhibiting the translation of key surface antigens without broadly halting overall cellular protein synthesis.
This selective translation defect allows malignant cells in colorectal cancer models and pathogenic viruses to escape immune detection. In preclinical investigations, dietary arginine restriction caused marked down-regulation of surface antigen expression, enabling tumors to grow unchecked and exacerbating morbidity during respiratory viral infection, including influenza and coronavirus strains. Conversely, restoring optimal nutritional intake rescued antigen presentation, suppressed primary tumor growth, and mitigated tissue injury.
Clinical Implications for Immunotherapy and Viral Defense
Because human plasma levels of amino acids often fluctuate with age and metabolic health, these findings offer potential therapeutic insights for patient care. Older adults and immunocompromised individuals frequently exhibit lower systemic arginine levels, which may partially explain observed decrements in cellular immune vigilance.
Targeting codon-dependent translation through nutritional modification or targeted amino acid supplementation may provide an accessible adjunct to existing immunotherapies. By restoring antigen presentation pathways, clinicians could potentially boost the efficacy of immune checkpoint inhibitors or enhance baseline resistance against acute viral pathogens. Further clinical trials will be necessary to establish precise dosing protocols and evaluate whether dietary intervention can replicate these robust preclinical responses in human patient populations.
Reference
Wu Q et al. Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection. Cell. 2026.
Featured Image: Collpicto on Adobe Stock.
